Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Entrada Therapeutics Inc (TRDA)

Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Entrada Therapeutics Inc One Design Center Place Suite 17-500 Boston MA 02210 USA

www.entradatx.com P: 857-520-9158

Description:

Entrada Therapeutics Inc. is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles(TM) to engage intracellular targets. Entrada Therapeutics Inc. is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 499,633
Enterprise Value, $K 432,033
Shares Outstanding, K 33,759
Annual Sales, $ 129,010 K
Annual Net Income, $ -6,680 K
Last Quarter Sales, $ 94,690 K
Last Quarter Net Income, $ 55,030 K
EBIT, $ 93,440 K
EBITDA, $ 90,500 K
60-Month Beta -0.24
% of Insider Shareholders 7.58%
% of Institutional Shareholders 86.39%
Float, K 31,200
% Float 92.42%
Short Volume Ratio 0.49

Growth:

1-Year Return 6.63%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.55 on 08/13/24
Next Earnings Date N/A
Earnings Per Share ttm 2.96
EPS Growth vs. Prev Qtr 127.94%
EPS Growth vs. Prev Year 298.72%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TRDA Ratios

Ratio
Price/Earnings ttm 5.20
Price/Earnings forward 22.76
Price/Earnings to Growth N/A
Return-on-Equity % 35.16%
Return-on-Assets % 20.41%
Profit Margin % -5.18%
Debt/Equity 0.00
Price/Sales 4.44
Price/Cash Flow N/A
Price/Book 1.21
Book Value/Share 12.73
Interest Coverage -1.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar